Used as a chiral intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting central nervous system disorders. Its oxazole core and fluoropyridine moiety enhance binding selectivity to certain neuronal receptors, making it valuable in developing neuroprotective agents. The (R)-enantiomer shows higher efficacy in modulating ion channel activity compared to the racemic form. It is also employed in structure-activity relationship studies for optimizing drug candidates with improved metabolic stability and blood-brain barrier penetration.